Gaganpreet Kaur, NP

Gaganpreet Kaur practices at Gustine Primary Care in Gustine, California.

Gaganpreet Kaur's NPI, 1821551953, was assigned on April 6, 2019. Gaganpreet Kaur holds California license 95011552.

Gaganpreet Kaur's primary practice is Gustine Primary Care, at 489 5th Street, Gustine, CA 95322 in Merced County. The practice phone is (209) 678-0990.

Gaganpreet Kaur's primary practice is Gustine Primary Care in Gustine, California. The medical group on file is Community Health Centers of America. Dmand AI also links Gaganpreet Kaur to 6 more medical groups, 2 group practices and clinics and 1 skilled nursing facility, each named with a free account. Gaganpreet Kaur's employer is on file too: a community health center (fqhc).

Dmand AI tracks the electronic health record (EHR) system at each site where Gaganpreet Kaur practices, 4 sites in all. Vendor and product names are available with a free account.

Family is Gaganpreet Kaur's primary specialty in the NPI Registry, under taxonomy code 363LF0000X. Gaganpreet Kaur is licensed in California.

Dmand AI lists alzheimer's disease, anxiety, arthritis, asthma, bipolar disorder, bladder disease, chronic diabetes and chronic kidney disease among the conditions Gaganpreet Kaur treats.

CMS data shows 6,119 Medicare services from Gaganpreet Kaur across 5 procedure codes in 2024, for 612 Medicare patients. Medicare paid $400,526 for them.

CMS counts 612 Medicare patients who saw Gaganpreet Kaur in 2024. The largest group is 65 to 74, with 212 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 69% are also on Medicaid. Their average risk score is 2.83, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Gaganpreet Kaur's median patient age at 75, with 58% women.

In 2024, Gaganpreet Kaur wrote 2,407 Medicare Part D claims for 251 patients. 87% of them were for generic drugs. CMS names the drug for 1,820 of them, across 51 drugs with 11 or more claims each, at $73,338 in total drug cost.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 99 out of 100 for Gaganpreet Kaur for performance year 2024, reported as part of a group. Gaganpreet Kaur accepts Medicare assignment, so Medicare's approved amount is taken as full payment.

CMS Open Payments shows 1 general payment to Gaganpreet Kaur from 1 drug or device company in 2025. Food and beverage make up the largest share, 100% of the total. Janssen Pharmaceuticals, Inc paid the most, $23.